Medical Condition News

RSS

Levels of IgG antibodies may influence COVID-19 outcomes

COVID-19, the source of the current pandemic, may be caused by a single virus, but it has a variety of presentations that make treatment difficult. Children, for example, almost exclusively experience mild or asymptomatic COVID-19, while adults can develop severe or even fatal COVID-19.

19 Feb 2021

Researcher performs study on consequences of fatphobia through her own experience

Nina Navajas Pertegás, assistant professor and researcher at the UV Department of Social Work and Social Services, has carried out a study on the consequences of fatphobia and the cultural imposition of thinness through her own experience, with a body itinerary that ranges from her childhood to adulthood.

19 Feb 2021

Stents or bypass surgery can improve outcomes in patients with stable ischemic heart disease

A recent study by University of Alberta cardiologists at the Canadian VIGOUR Centre shows that a particular group of patients with stable ischemic heart disease have better outcomes with percutaneous coronary intervention (also called angioplasty with stent) or coronary artery bypass surgery and medication, versus conservative management with medication alone.

18 Feb 2021

Specific cell-to-cell communication associated with progression of gastrointestinal stromal tumors

Gastrointestinal stromal tumors (GISTs) are a subytpe of cancers known as sarcomas. GIST is the most common type of sarcoma with approximately 5,000 to 6,000 new patient cases annually in the United States.

18 Feb 2021

Combination therapy produces clinical benefit for early stage non-small cell lung cancer

The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III non-small cell lung cancer (NSCLC) found combination therapy produced a significant clinical benefit, as assessed by major pathologic response (MPR) rate, as well as enhanced tumor immune cell infiltration and immunological memory.

18 Feb 2021

Henry Ford first in the U.S. to offer FDA-approved DBS system to treat Parkinson's disease

The Parkinson's Disease and Movement Disorder Center at Henry Ford Health System was the first in the United States to offer a new FDA-approved device to help treat the symptoms of Parkinson's disease.

18 Feb 2021

Researchers discover potential new way to target pancreatic tumors with high IFN signaling

UCLA Jonsson Comprehensive Cancer Center researchers have uncovered a potential new way to target pancreatic tumors that express high intratumoral interferon signaling (IFN).

18 Feb 2021

UC San Diego researchers launch clinical trial to test gene therapy for Alzheimer’s disease

Researchers at University of California San Diego School of Medicine have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons with Alzheimer's disease (AD) or Mild Cognitive Impairment (MCI), a condition that often precedes full-blown dementia.

18 Feb 2021

Study reveals extremely low detection of SARS-CoV-2 on surfaces in oncology facilities

Researchers from Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility.

18 Feb 2021

Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas

A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five years after receiving the chimeric antigen receptor (CAR) T cell therapy Kymriah, researchers in Penn's Abramson Cancer Center reported today in the New England Journal of Medicine.

18 Feb 2021

New study to explore how Apple Watch can provide early warning for worsening heart failure

As part of the University Health Network, renowned cardiologist Dr. Heather Ross has launched a new clinical study, in collaboration with Apple to test if remote monitoring with Apple Watch can help with early identification of worsening heart failure.

18 Feb 2021

Cone snail venom could potentially treat severe forms of malaria

Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.

18 Feb 2021

Study examines postoperative outcomes of coronary revascularization in people with and without Alzheimer’s

The risk of both mortality and rehospitalisation after an elective revascularisation procedure for coronary artery disease is similar for people with and without Alzheimer’s disease (AD), but people with AD had worse outcomes after an emergency procedure, according to a new study from the University of Eastern Finland.

18 Feb 2021

Launch of EMSO rapidly accesses ground-breaking cancer research from research to practice

ESMO, the leading organization for medical oncology, has launched an important new service for rapidly disseminating research to accelerate the transition of results into practice for the benefit of cancer patients.

18 Feb 2021

One in five people lack protein α-actinin-3 in their muscle fiber, shows study

Almost one in five people lack the protein α-actinin-3 in their muscle fibers. Researchers at Karolinska Institutet in Sweden now show that more of the skeletal muscle of these individuals comprises slow-twitch muscle fibers, which are more durable and energy-efficient and provide better tolerance to low temperatures than fast-twitch muscle fibers.

18 Feb 2021

Medical Condition News

Levels of IgG antibodies may influence COVID-19 outcomes

Researcher performs study on consequences of fatphobia through her own experience

Stents or bypass surgery can improve outcomes in patients with stable ischemic heart disease

Specific cell-to-cell communication associated with progression of gastrointestinal stromal tumors

Combination therapy produces clinical benefit for early stage non-small cell lung cancer

Henry Ford first in the U.S. to offer FDA-approved DBS system to treat Parkinson's disease

Researchers discover potential new way to target pancreatic tumors with high IFN signaling

UC San Diego researchers launch clinical trial to test gene therapy for Alzheimer’s disease

Study reveals extremely low detection of SARS-CoV-2 on surfaces in oncology facilities

Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas

New study to explore how Apple Watch can provide early warning for worsening heart failure

Cone snail venom could potentially treat severe forms of malaria

Study examines postoperative outcomes of coronary revascularization in people with and without Alzheimer’s

Launch of EMSO rapidly accesses ground-breaking cancer research from research to practice

One in five people lack protein α-actinin-3 in their muscle fiber, shows study

Study reveals genetic signature of colibactin implicated in the development colorectal cancers

New proton therapy targets treatment-resistant cancer cells

Researchers identify antibody that removes amyloid plaques without the risk of brain bleeds

Researchers measure baseline activity of single neurons

3D microscopy sheds light on the body’s immune response to obesity

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News